Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Heavy Ion FLASH

Project description

Stretching the frontiers of radiotherapy to treat cancer

Glioblastoma and other highly resistant tumours remain largely untreatable with conventional radiotherapy, as even the most advanced particle therapies are limited by damage to healthy tissue. The ERC-funded HI-FLASH project aims to harness the recently discovered FLASH effect, where ultra-high dose-rate irradiation spares normal tissue while destroying tumours. Pioneered at GSI, the project will use ions heavier than carbon, including neon, in preclinical models, employing 3D-printed modulators for precise treatment. By comparing survival, toxicity, and tumour control across conventional and ultra-high dose rates, HI-FLASH seeks to expand the therapeutic window, potentially transforming treatment options for patients facing the deadliest and most therapy-resistant cancers.

Objective

Charged particle therapy is generally acknowledged as the most advanced type of radiotherapy (RT). Particle therapy patients are treated either with high-energy protons or 12C-ions, but there is a general agreement that heavier ions would be highly beneficial in treating extremely resistant, hypoxic and lethal tumors, such as glioblastoma (GBM). Unfortunately, the use of very heavy ions is constrained by their excessive normal tissue toxicity.
A way to enable very heavy ion therapy with acceptable toxicities is to make use of the recently discovered FLASH effect. This effect occurs when ultra-high dose-rate (UHDR) electrons or protons are used and results in significantly sparing the normal tissues whilst maintaining tumour control. Although the molecular mechanism is still unclear, the FLASH effect considerably broadens the therapeutic window and has proven to be a game-changer in radiotherapy. While my group at GSI has pioneered the first demonstration of the FLASH effect with high-energy carbon ions, UHDR use of even heavier ions can be safe and very effective for very resistant tumor.
GSI is the only facility world-wide where the FLASH effect can be explored with ions heavier than carbon. In fact, the GSI synchrotron can accelerate all ions for H to U up to very high energy and intensity, and my group has developed a unique technology to perform 3D conformal UHDR irradiation using 3D-printed range modulators. We will perform UHDR irradiation experiments with 20Ne-ions using a GBM rat model and will compare survival, toxicity and tumour control with the same ion at conventional dose-rate and with UHDR protons as a reference. If successful, HI-FLASH will pave the way for the use of heavy ions in cancer treatment, improving outcomes for patients with highly resistant and lethal tumors like GBM.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-ADG

See all projects funded under this call

Host institution

GSI HELMHOLTZZENTRUM FUR SCHWERIONENFORSCHUNG GMBH
Net EU contribution
€ 2 500 000,00
Address
PLANCKSTRASSE 1
64291 Darmstadt
Germany
Region
Hessen Darmstadt Darmstadt, Kreisfreie Stadt
Activity type
Other
Links
Total cost
No data

Beneficiaries (1)